Evolution and heterogeneity of lethal metastatic bladder cancer subtypes - Nature
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes Nature
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes Nature
3-Factor Model May Simplify Risk Stratification in Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Cleveland Clinic
Light and Radiation Combo Doubles Survival in Rat Bladder Cancer Model Bioengineer.org
Study establishes foundational landscape of tumor evolution in bladder cancer News-Medical
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages Pharmacy Times
Surgeons now using ‘pretzels’ to spare bladder for noninvasive bladder cancer patients Vanderbilt Health News
Bladder Urothelial Carcinoma Diagnosed by Perineal Cutaneous Biopsy: A Case Report Cureus
ASTRO publishes its 1st clinical guidelines on radiation therapy for bladder cancer Radiology Business
Non-invasive urine test identifies 9 in 10 bladder cancers Oncology Central
A urine sample for the early detection of bladder cancer Hospital Clínic Barcelona
New Combination Therapy Shows Promise for Advanced Bladder Cancer University of Colorado Anschutz
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery Mayo Clinic News Network
Bladder Cancer Therapy Enfortumab Vedotin (Padcev®) Provides Lasting Benefits, Long-Term Data Confirms Memorial Sloan Kettering Cancer Center
Urine test detects 9 in 10 bladder cancers in NHS study healthcare-in-europe.com
Podcast: Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities ASCO Daily News
3 reasons why an accurate bladder cancer diagnosis matters mdanderson.org
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer NEJM
Bladder Cancer Treatment Is Advancing Faster Than Answers on Sequencing and Toxicity Management Pharmacy Times
Epithelial tumor suppressor deletion promotes neuroendocrine differentiation in bladder cancer and reveals homoharringtonine as a candidate vulnerability Nature
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer ascopubs.org
Key Bladder Cancer Trials to Watch in 2026 Oncology News Central
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer. AstraZeneca
Beyond the diagnosis: What living with bladder cancer really looks like jnj.com
After Six Years of Bladder Cancer, a New Bladder Helps Colorado Woman Look Forward Intermountain Health Newsroom
Xpert bladder cancer detection and monitor in urothelial carcinoma: systematic review and meta-analysis Nature
Spatial map of bladder cancer reveals hidden tumor environments and new paths toward precision therapy mdanderson.org
The Most Asked Bladder Cancer Questions: Signs, Symptoms, Stages and Treatment Options Cure Today
A Urine Test That Could Change the Course of Bladder Cancer Care Stanford Medicine
Immune Biomarkers May Predict Response to Bladder Cancer Treatment news.feinberg.northwestern.edu
ASCO 2026: Discussant – Curing Early Bladder Cancer with Multidisciplinary Approaches UroToday
A new sensor could enable earlier detection of bladder cancer MIT News
New study looks at pesticide exposure and bladder cancer risk among Hmong farmworkers UC Davis Health
Bladder Cancer Treatment Is Changing: What Patients Should Know Cure Today
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms ascopubs.org
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer in the Phase III VOLGA trial AstraZeneca
Bladder Cancer: Should Cystectomy Be Avoided? Oncology News Central
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing CancerNetwork
Five stories. One fight. What it means to live with bladder cancer. jnj.com
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial Nature
WVU Cancer Institute expands bladder cancer treatment options for patients across region WVU Medicine